Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Alpha and Omega Semiconductor
AOSL
$851M
| $12.1M | 0.01% |
889,700
-87,604
| -9% | -$1.19M |
|
1327
iRhythm Technologies
IRTC
$5.75B
| $12.1M | 0.01% |
+177,500
| New | +$12.1M |
|
|
GSB
1328
DELISTED
GlobalSCAPE, Inc.
GSB
| $12.1M | 0.01% |
1,228,390
+14,046
| +1% | +$138K |
|
1329
German American Bancorp
GABC
$1.53B
| $12M | 0.01% |
337,100
-12,300
| -4% | -$438K |
|
|
SEI
1330
Solaris Energy Infrastructure, Inc.
SEI
$1.38B
| $12M | 0.01% |
853,575
+103,800
| +14% | +$1.45M |
|
1331
Antero Resources
AR
$10.3B
| $11.9M | 0.01% |
4,188,700
-228,097
| -5% | -$650K |
|
|
CEL
1332
DELISTED
Cellcom Israel, Ltd.
CEL
| $11.9M | 0.01% |
3,789,672
+21,695
| +0.6% | +$68.3K |
|
1333
Wipro
WIT
$29B
| $11.9M | 0.01% |
6,366,054
+87,520
| +1% | +$164K |
|
1334
TopBuild
BLD
$11.7B
| $11.9M | 0.01% |
115,400
+56,600
| +96% | +$5.83M |
|
1335
Teekay
TK
$725M
| $11.9M | 0.01% |
2,233,465
+329,400
| +17% | +$1.75M |
|
1336
iShares MBS ETF
MBB
$41.4B
| $11.9M | 0.01% |
109,845
+37,517
| +52% | +$4.05M |
|
|
BRT
1337
BRT Apartments
BRT
$292M
| $11.9M | 0.01% |
698,787
+66,245
| +10% | +$1.12M |
|
1338
LyondellBasell Industries
LYB
$17.7B
| $11.8M | 0.01% |
+125,400
| New | +$11.8M |
|
|
GLIBA
1339
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $11.8M | 0.01% |
167,210
+157,800
| +1,677% | +$11.2M |
|
|
NTUS
1340
DELISTED
Natus Medical Inc
NTUS
| $11.8M | 0.01% |
358,945
+120,345
| +50% | +$3.97M |
|
|
HMTV
1341
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $11.8M | 0.01% |
796,000
+18,200
| +2% | +$270K |
|
1342
Knowles
KN
$1.88B
| $11.8M | 0.01% |
556,674
+494,000
| +788% | +$10.4M |
|
|
HNGR
1343
DELISTED
Hanger Inc.
HNGR
| $11.8M | 0.01% |
425,862
-117,400
| -22% | -$3.24M |
|
1344
Maximus
MMS
$5.06B
| $11.8M | 0.01% |
158,000
+151,100
| +2,190% | +$11.2M |
|
1345
Imperial Oil
IMO
$46.6B
| $11.7M | 0.01% |
443,458
+147,958
| +50% | +$3.92M |
|
1346
Aurinia Pharmaceuticals
AUPH
$1.65B
| $11.7M | 0.01% |
578,534
+567,789
| +5,284% | +$11.5M |
|
1347
Cencora
COR
$59.2B
| $11.7M | 0.01% |
+137,700
| New | +$11.7M |
|
|
PTNR
1348
DELISTED
Partner Communications
PTNR
| $11.7M | 0.01% |
2,682,550
+4,000
| +0.1% | +$17.4K |
|
1349
eGain
EGAN
$222M
| $11.7M | 0.01% |
1,475,921
-14,200
| -1% | -$112K |
|
1350
Travere Therapeutics
TVTX
$2.11B
| $11.6M | 0.01% |
816,827
+135,902
| +20% | +$1.93M |
|